<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="viewport" content="width=device-width,initial-scale=1"><meta name="robots" content="noindex"><!-- Begin Jekyll SEO tag v2.8.0 --><title>Engelberg Center News</title><meta name="generator" content="Jekyll v3.9.2"><meta property="og:title" content="Engelberg Center News"><meta property="og:locale" content="en_US"><link rel="canonical" href="https://objectively.github.io/engelberg/news/"><meta property="og:url" content="https://objectively.github.io/engelberg/news/"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><meta property="twitter:title" content="Engelberg Center News"><script type="application/ld+json">{"@context":"https://schema.org","@type":"WebPage","headline":"Engelberg Center News","url":"https://objectively.github.io/engelberg/news/"}</script><!-- End Jekyll SEO tag --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:title" content="Engelberg Center News"><meta name="twitter:description" content=""><title>Engelberg Center News</title><link rel="shortcut icon" href="/engelberg/images/favicon.ico" type="image/x-icon"><!-- <link rel="stylesheet" href="/engelberg/vendor/styleguide-v2.1.css"> --><link rel="stylesheet" href="/engelberg/vendor/foundation.min.css"><link rel="stylesheet" href="/engelberg/assets/style.min.css"><!-- <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet"> --><link href="https://fonts.googleapis.com/css?family=Material+Icons|Material+Icons+Outlined|Material+Icons+Two+Tone|Material+Icons+Round|Material+Icons+Sharp" rel="stylesheet"><link rel="preconnect" href="https://fonts.googleapis.com"><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link href="https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;700&family=Roboto+Condensed:wght@300;400;700&display=swap" rel="stylesheet"></head><body><a href="/engelberg/news/#main" class="skip-to-main-content-link">Skip to main content</a><header class="top-bar top-bar--white"><button class="top-bar__menu-button js-trigger-menu js-trigger-menu--left"><span class="menu-button__decorator"></span> <span class="menu-button__text">menu</span></button><div class="top-bar__logo-container"><img class="logo" alt="logo" src="/engelberg/images/ec-icon-color.svg"></div><nav class="main-nav"><a href="#" class="close-button"><i class="material-icons">close</i></a> <a class="home-button" href="/engelberg/"><i class="material-icons">home</i></a><div class="row expanded"><div class="column large-3 small-12 medium-6 link-column"><span class="header-link header-link--no-hover">Individual Pages</span> <a href="/engelberg/">Index</a> <a href="/engelberg/what-we-do">What We Do</a> <a href="/engelberg/for-students">For Students</a></div><div class="column large-4 small-12 medium-6 link-column"><span class="header-link header-link--no-hover">Generated Pages</span><div class="row expanded no-padding"><div class="column large-12"><a href="/engelberg/our-people">Our People</a> <a href="/engelberg/our-mission">Our Mission</a> <a href="/engelberg/getting-involved">Getting Involved</a> <a href="/engelberg/our-people/michael-weinberg">Michael Weinberg (Profile Template)</a></div></div></div><div class="column large-3 small-12 medium-6 link-column"><span class="header-link header-link--no-hover">Landing Pages</span> <a href="/engelberg/projects">Projects</a> <a href="/engelberg/events">Events</a></div><div class="column large-2 small-12 medium-6 link-column link-column--logo"><span class="header-link header-link--no-hover">List Pages</span> <a href="/engelberg/products">Products</a> <a href="/engelberg/news">News</a> <img class="logo" alt="logo" src="/engelberg/images/ec-icon-color.svg"></div></div></nav></header><!-- LAYOUT 9: Lists  --><main id="main" class="product-list-page"><section id="product-list"><div class="row expanded no-padding list-row"><aside class="list-aside filter-container"><div class="column large-offset-2"><h1>Engelberg Center News</h1><div class="bar"></div><span class="search-title">Filters</span> <button class="clear-filters">Clear all</button><div class="dropdown-container"><div class="dropdown-component"><label class="visually-hidden" for="news-authors" aria-label="news_authors">news_authors</label> <select class="dropdown" name="news_authors" id="news-authors"><option id="all-news_authors" value="all">All Center People</option><option id="albert-fox-cahn" value="albert-fox-cahn">Albert Fox Cahn</option><option id="barton-beebe" value="barton-beebe">Barton Beebe</option><option id="christopher-jon-sprigman" value="christopher-jon-sprigman">Christopher Jon Sprigman</option><option id="christopher-morten" value="christopher-morten">Christopher Morten</option><option id="jane-anderson" value="jane-anderson">Jane Anderson</option><option id="jason-m-schultz" value="jason-m-schultz">Jason M. Schultz</option><option id="jeanne-fromer" value="jeanne-fromer">Jeanne Fromer</option><option id="jennie-rose-halperin" value="jennie-rose-halperin">Jennie Rose Halperin</option><option id="kyle-k-courtney" value="kyle-k-courtney">Kyle K. Courtney</option><option id="michael-weinberg" value="michael-weinberg">Michael Weinberg</option><option id="navya-dasari" value="navya-dasari">Navya Dasari</option><option id="patricia-martone" value="patricia-martone">Patricia Martone</option><option id="rochelle-c-dreyfuss" value="rochelle-c-dreyfuss">Rochelle C. Dreyfuss</option><option id="sarah-feingold" value="sarah-feingold">Sarah Feingold</option></select></div></div><div class="dropdown-container"><div class="dropdown-component"><label class="visually-hidden" for="news-publications" aria-label="news-publications">news-publications</label> <select class="dropdown" name="news-publications" id="news-publications"><option id="all-news-publications" value="all">Publication</option><option id="3d-printing-industry" value="3d-printing-industry">3D Printing Industry</option><option id="aba-journal" value="aba-journal">ABA Journal</option><option id="bloomberg-law" value="bloomberg-law">Bloomberg Law</option><option id="business-of-home" value="business-of-home">Business of Home</option><option id="chemical-engineering-news" value="chemical-engineering-news">Chemical & Engineering News</option><option id="dwell" value="dwell">Dwell</option><option id="endpoint-news" value="endpoint-news">Endpoint News</option><option id="engelberg-center" value="engelberg-center">Engelberg Center</option><option id="engelberg-center-news" value="engelberg-center-news">Engelberg Center News</option><option id="financial-times" value="financial-times">Financial Times</option><option id="jacobin" value="jacobin">Jacobin</option><option id="law-com" value="law-com">Law.com</option><option id="law360" value="law360">Law360</option><option id="new-york-times" value="new-york-times">New York Times</option><option id="newsweek" value="newsweek">Newsweek</option><option id="observer" value="observer">Observer</option><option id="rolling-stone" value="rolling-stone">Rolling Stone</option><option id="sf-chronicle" value="sf-chronicle">SF Chronicle</option><option id="stat-news" value="stat-news">Stat News</option><option id="teen-vogue" value="teen-vogue">Teen Vogue</option><option id="the-brian-lehrer-show" value="the-brian-lehrer-show">The Brian Lehrer Show</option><option id="the-fashion-law" value="the-fashion-law">The Fashion Law</option><option id="the-new-yorker" value="the-new-yorker">The New Yorker</option><option id="the-washington-post" value="the-washington-post">The Washington Post</option><option id="time" value="time">Time</option></select></div></div><div class="dropdown-container"><div class="dropdown-component"><label class="visually-hidden" for="news-types" aria-label="news-types">news-types</label> <select class="dropdown" name="news-types" id="news-types"><option id="all-news-types" value="all">Type</option><option id="announcement" value="announcement">Announcement</option><option id="in-the-news" value="in-the-news">In the News</option></select></div></div></div></aside><div class="column large-offset-1 large-7 no-padding"><h2>Results</h2><div class="results-container"><p><span id="results-total"></span> <span id="results-filter-detail"></span></p></div><div class="date-toggle-container"><button type="button" class="button__date-sort button__sort--descending js-sort sort" data-sort="timestamp">Date</button></div><div class="list"><div class="news-list-item"><a class="external-link" href="https://www.law360.com/newyork/articles/1544054/less-than-10-of-patent-trial-teams-are-led-by-women"><span class="news-list-item__title">Less Than 10% Of Patent Trial Teams Are Led By Women</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Law360</span> <span class="news-list-item__authors"><p>Patricia Martone</p></span><span class="news-list-item__date">November 02, 2022</span><p class="news-list-item__description">Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://news.bloomberglaw.com/ip-law/needle-barely-moved-for-woman-led-patent-trials-report-says"><span class="news-list-item__title">‘Needle Barely Moved’ for Woman-Led Patent Trials, Report Says</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Bloomberg Law</span> <span class="news-list-item__authors"><p>Patricia Martone</p></span><span class="news-list-item__date">November 02, 2022</span><p class="news-list-item__description">Women continue to face barriers in leading patent trials after a decade of almost no growth kept their share of first chair roles under 10%, according to a report by Patricia A. Martone, a long-time female patent trial lawyer.</p><div class="tags-container"></div></div><div class="news-list-item"><a href="/engelberg/news/announcing-womens-struggle-to-become-first-chair-trial-lawyers-in-patent-cases-lots-of-talk-but-little-progress"><span class="news-list-item__title">Announcing "Women's Struggle to Become First Chair Trial Lawyers in Patent Cases: Lots of Talk but Little Progress"</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Engelberg Center</span> <span class="news-list-item__authors"><p>Patricia Martone</p></span><span class="news-list-item__date">November 02, 2022</span><p class="news-list-item__description">Analyzing data starting in 2010 and drawing from 26 years of personal experience as a First Chair patent litigator, Engelberg Center Fellow Patricia Martone explores the current state of women at the top of patent litigation.</p><div class="tags-container"></div></div><div class="news-list-item"><a href="/engelberg/news/library-futures-joins-the-engelberg-center"><span class="news-list-item__title">Library Futures Joins the Engelberg Center</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Engelberg Center News</span> <span class="news-list-item__authors"></span> <span class="news-list-item__date">September 12, 2022</span><p class="news-list-item__description">We are excited to announce that the nonprofit project Library Futures is joining the Engelberg Center.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.dwell.com/article/state-of-knock-off-furniture-e-commerce-direct-to-consumer-23d2e44f"><span class="news-list-item__title">How E-Commerce Changed the Knock-Off Furniture Game</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Dwell</span> <span class="news-list-item__authors"><p>Christopher Sprigman</p></span><span class="news-list-item__date">November 16, 2022</span><p class="news-list-item__description">Direct-to-consumer revolutionized the furniture market. What’s at stake when fakes are easier to find than ever?</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://cen.acs.org/policy/intellectual-property/Moderna-sues-Pfizer-BioNTech-over/100/web/2022/08"><span class="news-list-item__title">Moderna sues Pfizer and BioNTech over COVID-19 vaccine</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Chemical & Engineering News</span> <span class="news-list-item__authors"></span> <span class="news-list-item__date">August 31, 2022</span><p class="news-list-item__description">Moderna is effectively claiming that the pandemic is over, says Rochelle C. Dreyfuss, a professor at the New York University School of Law.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://news.bloomberglaw.com/us-law-week/high-courts-tricky-task-in-warhol-case-carries-big-implications"><span class="news-list-item__title">High Court’s Tricky Task in Warhol Case Carries Big Implications</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Bloomberg Law</span> <span class="news-list-item__authors"><p>Jason Schultz</p></span><span class="news-list-item__date">April 01, 2022</span><p class="news-list-item__description">The U.S. Supreme Court will face the challenge of crafting objective guidance for answering a subjective question about fair use as it weighs whether an Andy Warhol print infringes a photo of Prince.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.rollingstone.com/culture/culture-features/black-creator-tiktok-strike-dance-law-1334553/"><span class="news-list-item__title">Why Is It So Hard for Black Creators to Get Their Due?</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Rolling Stone</span> <span class="news-list-item__authors"><p>Christopher Sprigman</p></span><span class="news-list-item__date">April 28, 2022</span><p class="news-list-item__description">A year after the TikTok “dance strike,” Black dancers looking for credit and compensation from social media face a complicated landscape.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://3dprintingindustry.com/news/biden-issues-new-rule-to-crack-down-on-ghost-guns-3d-printing-industry-responds-208052/"><span class="news-list-item__title">Biden issues new rule to crack down on ‘ghost guns,’ 3D printing industry responds</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">3D Printing Industry</span> <span class="news-list-item__authors"><p>Michael Weinberg</p></span><span class="news-list-item__date">March 21, 2022</span><p class="news-list-item__description">Legal experts and gunmaking hobbyists have cast doubt over the relevance of US President Joe Biden’s upcoming ‘ghost gun’ reforms to the 3D printing industry.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://observer.com/2022/03/putins-war-on-intellectual-property-has-only-just-begun/"><span class="news-list-item__title">Putin’s War on Intellectual Property Has Only Just Begun</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Observer</span> <span class="news-list-item__authors"><p>Michael Weinberg</p></span><span class="news-list-item__date">March 17, 2022</span><p class="news-list-item__description">With a new decree, Russia has essentially made patent theft legal.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.nytimes.com/2022/03/11/technology/apple-trademarks.html"><span class="news-list-item__title">Apps and Oranges: Behind Apple’s ‘Bullying’ on Trademarks</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">New York Times</span> <span class="news-list-item__authors"><p>Barton Beebe</p></span><span class="news-list-item__date">March 17, 2022</span><p class="news-list-item__description">The company has opposed singer-songwriters, school districts and food blogs for trying to trademark names or logos featuring an apple — or a pear or pineapple.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.law.com/corpcounsel/2021/11/22/gc-turned-playwright-shares-true-in-house-tales-of-sex-drugs-and-rock-n-roll/?slreturn=20221111154820"><span class="news-list-item__title">Is Europe Running Out of Trademarks? Professor Beebe Talks EU Trade Mark Depletion</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Law.com</span> <span class="news-list-item__authors"><p>Barton Beebe</p></span><span class="news-list-item__date">November 22, 2021</span><p class="news-list-item__description">Is the European trademark system a victim of its own success? This was the question posed by Professor Barton Beebe of NYU School of Law at the Annual Sir Hugh Laddie Lecture at UCL-IBIL on November 9.</p><div class="tags-container"></div></div><div class="news-list-item"><a href="/engelberg/news/announcing-distributed-manufacturing-of-open-hardware"><span class="news-list-item__title">Announcing “Distributed Manufacturing of Open Hardware: A Report of the Open Hardware Distribution & Documentation Working Group”</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Engelberg Center News</span> <span class="news-list-item__authors"><p>Michael Weinberg</p></span><span class="news-list-item__date">November 02, 2021</span><p class="news-list-item__description">While the open and distributed design promise of open hardware has been realized time and time again, the goal of truly distributed manufacture of hardware has proven harder to achieve.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.statnews.com/pharmalot/2021/01/26/patents-drug-prices-morten-1498-march-in/"><span class="news-list-item__title">This professor wrote a manual for using a little-known federal law for lowering drug prices</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Stat News</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">January 26, 2021</span><p class="news-list-item__description">One of the priorities of the new Biden administration is to tackle the cost of prescription medicines, an elusive goal for many federal and state lawmakers over the past several years.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.sfchronicle.com/health/article/COVID-19-drug-remdesivir-has-been-a-big-win-for-15901000.php"><span class="news-list-item__title">COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">SF Chronicle</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">January 27, 2021</span><p class="news-list-item__description"></p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.newsweek.com/marvels-punisher-problem-1574579"><span class="news-list-item__title">Marvel's Punisher Problem</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Newsweek</span> <span class="news-list-item__authors"><p>Jeanne Fromer</p></span><span class="news-list-item__date">March 10, 2021</span><p class="news-list-item__description">Marvel has a popularity problem with one of its B-list characters: the Punisher, aka Frank Castle, a troubled ex-Marine turned vigilante who metes out lethal justice to the corrupt and criminal. Right now he's too popular with the wrong people.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.nytimes.com/2021/03/21/world/vaccine-patents-us-eu.html"><span class="news-list-item__title">Rich Countries Signed Away a Chance to Vaccinate the World</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">New York Times</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">March 21, 2021</span><p class="news-list-item__description"></p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.statnews.com/pharmalot/2021/03/25/covid19-coronavirus-vaccnie-moderna-patents-nih-hhs/"><span class="news-list-item__title">HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Stat News</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">March 25, 2021</span><p class="news-list-item__description">Seeking to quickly widen global access to Covid-19 vaccines, a group of academics and patient advocates is urging the Biden administration to use a key patent owned by the U.S. government to boost manufacturing and distribution of the Moderna (MRNA) shot.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://news.bloomberglaw.com/health-law-and-business/covid-19-vaccine-deal-making-is-fleeting-game-changer-for-pharma"><span class="news-list-item__title">Covid-19 Vaccine Deal-Making Is Fleeting Game Changer for Pharma</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Bloomberg Law</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">March 29, 2021</span><p class="news-list-item__description">Major drugmakers are teaming up at an unprecedented rate to meet Covid-19 vaccine production demands, but industry watchers say the drive may be short-lived.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.wnyc.org/story/what-know-about-new-yorks-vaccine-passport/"><span class="news-list-item__title">What to Know About New York's 'Vaccine Passport'</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">The Brian Lehrer Show</span> <span class="news-list-item__authors"><p>Albert Fox Cahn</p></span><span class="news-list-item__date">March 30, 2021</span><p class="news-list-item__description">Albert Fox Cahn, founder and executive director of the Surveillance Technology Oversight Project (STOP) at the Urban Justice Center, a New York–based civil rights and privacy group, shares concerns about privacy and the digital divide.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.statnews.com/pharmalot/2021/03/31/gilead-remdesivir-patents-covid19-veklury/"><span class="news-list-item__title">The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Stat News</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">March 31, 2021</span><p class="news-list-item__description">American taxpayers may have provided $162 million toward researching remdesivir, but the federal government does not have patent rights for the drug.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://endpts.com/us-government-does-not-own-any-remdesivir-patents-gao-report-finds/"><span class="news-list-item__title">US government does not own any remdesivir patents, GAO report finds</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Endpoint News</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">April 01, 2021</span><p class="news-list-item__description">The US federal government’s contributions to research on Gilead’s Covid-19 antiviral drug remdesivir did not result in any patent rights because the research did not create new inventions, the Government Accountability Office said in a report.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://time.com/5952718/google-oracle-supreme-court/"><span class="news-list-item__title">How Google’s Big Supreme Court Victory Could Change Software Forever</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Time</span> <span class="news-list-item__authors"><p>Jeanne Fromer</p></span><span class="news-list-item__date">April 06, 2021</span><p class="news-list-item__description">The Court ruled that Google did not violate copyright law when it included parts of Oracle’s Java programming code in its Android operating system—ending a decade-long multibillion dollar legal battle.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.newyorker.com/magazine/2021/04/19/how-did-a-self-taught-linguist-come-to-own-an-indigenous-language"><span class="news-list-item__title">How Did a Self-Taught Linguist Come to Own an Indigenous Language?</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">The New Yorker</span> <span class="news-list-item__authors"><p>Jane Anderson</p></span><span class="news-list-item__date">April 12, 2021</span><p class="news-list-item__description">The Penobscot language was spoken by almost no one when Frank Siebert set about trying to preserve it. The people of Indian Island are still reckoning with his legacy.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://endpts.com/law-professors-call-for-fda-to-disclose-all-safety-and-efficacy-data-for-drugs/"><span class="news-list-item__title">Vaccine patent gives US government 'leverage' over manufacturers</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Financial Times</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">April 21, 2021</span><p class="news-list-item__description"></p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://endpts.com/law-professors-call-for-fda-to-disclose-all-safety-and-efficacy-data-for-drugs/"><span class="news-list-item__title">Law professors call for FDA to disclose all safety and efficacy data for drugs</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Endpoint News</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">April 21, 2021</span><p class="news-list-item__description">Back in early 2018 when Scott Gottlieb led the FDA, there was a moment when the agency seemed poised to release redacted complete response letters and other previously undisclosed data. But that initiative never gained steam.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://jacobin.com/2021/04/moderna-patents-covid-19-vaccine"><span class="news-list-item__title">Moderna’s Pledge Not to Enforce the Patents on Their COVID-19 Vaccine Is Worthless</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Jacobin</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">April 22, 2021</span><p class="news-list-item__description">The media cheered Moderna’s pledge not to enforce the patents on its COVID-19 vaccine. But vaccines like theirs are still protected by intellectual property laws designed to keep medical knowledge out of the public’s hands.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.statnews.com/pharmalot/2021/04/28/fda-acceleron-clinical-trials-transparency/"><span class="news-list-item__title">For the first time, the FDA may fine a drug maker for failing to post clinical trial results</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Stat News</span> <span class="news-list-item__authors"><p>Christopher Morten</p></span><span class="news-list-item__date">April 28, 2021</span><p class="news-list-item__description">The Food and Drug Administration is threatening to fine Acceleron Pharma (XLRN) for failing to submit required information about a clinical trial to a federal registry.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.teenvogue.com/story/vaccine-nationalism-what-is"><span class="news-list-item__title">Vaccine Nationalism: What Is It and How Is It Playing Out During COVID-19?</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Teen Vogue</span> <span class="news-list-item__authors"><p>Navya Dasari</p></span><span class="news-list-item__date">May 06, 2021</span><p class="news-list-item__description">After exploring the fallout from @DesignWithinCopy and taking a deep dive into the law and culture around knockoffs, Business of Home spoke to Sprigman to get a provocative new perspective on the subject of copycatting.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://businessofhome.com/articles/are-knockoffs-really-so-bad"><span class="news-list-item__title">Are knockoffs really so bad?</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Business of Home</span> <span class="news-list-item__authors"><p>Christopher Sprigman</p></span><span class="news-list-item__date">August 18, 2021</span><p class="news-list-item__description">After exploring the fallout from @DesignWithinCopy and taking a deep dive into the law and culture around knockoffs, Business of Home spoke to Sprigman to get a provocative new perspective on the subject of copycatting.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.thefashionlaw.com/the-potential-downside-of-design-competitions-the-risk-of-rip-offs/"><span class="news-list-item__title">The Potential Downside of Design Competitions? The Risk of Rip-Offs</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">The Fashion Law</span> <span class="news-list-item__authors"><p>Christopher Sprigman</p></span><span class="news-list-item__date">August 20, 2021</span><p class="news-list-item__description">Law students from coast to coast are getting more hands-on training in privacy, as schools use technology clinics for training in an area of the law that’s exploding in popularity at firms and social justice organizations.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.law.com/corpcounsel/2021/11/22/gc-turned-playwright-shares-true-in-house-tales-of-sex-drugs-and-rock-n-roll/?slreturn=20221111154820"><span class="news-list-item__title">GC-Turned-Playwright Shares True In-House Tales of 'Sex, Drugs and Rock 'N' Roll'</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Law.com</span> <span class="news-list-item__authors"><p>Sarah Feingold</p></span><span class="news-list-item__date">November 19, 2021</span><p class="news-list-item__description">"We have stories about having sex on the roof. We have stories about prescription drugs, illegal drugs. We have stories about alleged illicit arms trading, a fire, a dog," said Sarah Feingold, a playwright and former GC for Etsy.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.law.com/corpcounsel/2021/11/22/gc-turned-playwright-shares-true-in-house-tales-of-sex-drugs-and-rock-n-roll/?slreturn=20221111154820"><span class="news-list-item__title">From Harvard to Berkeley, Clinics Train Next-Gen Tech Lawyers</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Bloomberg Law</span> <span class="news-list-item__authors"><p>Jason Schultz</p></span><span class="news-list-item__date">August 25, 2021</span><p class="news-list-item__description">Law students from coast to coast are getting more hands-on training in privacy, as schools use technology clinics for training in an area of the law that’s exploding in popularity at firms and social justice organizations.</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.law360.com/articles/1458997/breyer-s-rulings-shaped-by-wariness-of-intellectual-property"><span class="news-list-item__title">Breyer's Rulings Shaped By Wariness Of Intellectual Property</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">Law360</span> <span class="news-list-item__authors"><p>Jeanne Fromer</p></span><span class="news-list-item__date">January 27, 2022</span><p class="news-list-item__description"></p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.abajournal.com/web/article/abas-antitrust-law-section-hopes-to-attract-more-students-to-practice-with-free-casebook"><span class="news-list-item__title">ABA’s Antitrust Law Section hopes to attract more students to practice with free casebook</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">ABA Journal</span> <span class="news-list-item__authors"><p>Christopher Sprigman</p></span><span class="news-list-item__date">March 09, 2022</span><p class="news-list-item__description">“The [copyright] casebook has quickly become very widely used,” Sprigman says. “We’re in use at about 60 law schools. We’re in our third edition now. We revise it every summer."</p><div class="tags-container"></div></div><div class="news-list-item"><a class="external-link" href="https://www.washingtonpost.com/business/2020/05/26/remdesivir-coronavirus-taxpayers/"><span class="news-list-item__title">Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price</span> </a><span class="news-list-item__subtitle"></span> <span class="news-list-item__publication">The Washington Post</span> <span class="news-list-item__authors"><p>Technology Law &amp; Policy Clinic</p></span><span class="news-list-item__date">May 26, 2020</span><p class="news-list-item__description">The HIV-prevention advocacy group PrEP4All Collaboration, working with the Technology Law & Policy Clinic at New York University, released an analysis Tuesday that said the government probably has a legal right to claim it co-invented remdesivir.</p><div class="tags-container"></div></div></div></div></div></section></main><div id="overlay" class="js-overlay"></div><script src="https://code.jquery.com/jquery-3.4.1.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><script type="text/javascript" src="/engelberg/vendor/twitterFetcher_min.js"></script><script src="/engelberg/assets/bundle.js"></script></body></html>